- Home
- FluxMPS™ Minimum Essential Medium (MEM), High Glucose, NEAA & 25mM HEPES w/o Sodium Pyruvate, Phenol Red: 1X Liquid
FluxMPS™ Minimum Essential Medium (MEM), High Glucose, NEAA & 25mM HEPES w/o Sodium Pyruvate, Phenol Red: 1X Liquid
FluxMPS™ DCP-MEMGH-PR1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) MEM High Glucose + NEAA + 25 mM HEPES formulation engineered for primary neurons and related primary cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration. NEAA is pre-loaded to reduce metabolic burden on primary cells, and 25 mM HEPES (pKa 7.3 at 37°C) provides robust pH buffering outside a CO2 incubator. Formulation: [+] Earle's Salts, [+] NEAA, [+] High Glucose (4500 mg/L), [+] L-Glutamine, [+] Sodium Bicarbonate, [+] 25 mM HEPES | [-] Sodium Pyruvate, [-] Phenol Red.
- High Glucose (4.5 g/L) with Earle's Salts and NEAA supports energy-demanding primary neurons, cardiomyocytes and epithelial cells.
- NEAA pre-loaded reduces de novo synthesis burden and ammonia accumulation in low-serum primary cell culture.
- 25 mM HEPES (pKa 7.3 at 37°C) buffers pH during open-air handling, flow cytometry preparation and atmospheric incubation.
- Formulated without sodium pyruvate and without phenol red for imaging-clean, low optical-interference primary cell assays.
- Quadruple-stage filtration (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final cut-off — Microfluidics Suitable for OoC and MPS platforms.
- Endotoxin release specification < 0.05 EU/mL (LAL, USP <85>), verified per manufacturing batch.
- Manufactured under an ISO 13485:2016 quality management system with a per-lot Certificate of Analysis.
- Media familyMEM High Glucose + NEAA + 25mM HEPES (Earle's Salts base)
- Glucose4500 mg/L (4.5 g/L, High Glucose)
- HEPES25 mM (5958 mg/L), pKa 7.3 at 37°C
- NEAAPresent
- Formulation[+] L-Glutamine, [+] Sodium Bicarbonate, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Glucose | [-] Phenol Red, [-] Sodium Pyruvate
- AppearancePale yellow, clear solution (phenol red–free)
- pH (USP <791>)7.4
- Osmolality (USP <785>)290–330 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2
Engineered for primary cell culture where standard media fails
MEM with Earle's Salts is a foundational primary cell medium, but conventional 0.22 µm filtered MEM permits mycoplasma, subvisible particulates and endotoxin that can alter primary cell phenotype. FluxMPS™ addresses these failure modes while preserving the full nutritional profile primary cells depend on.
Microchannel-safe purity
0.04 µm final filtration with USP <788> particulate compliance. Low-particulate primary cell media helps prevent chip channel clogging in sub-100 µm geometries.
Primary cell–optimized formulation
MEM + Earle's Salts + NEAA: an established base for primary fibroblasts, neurons, epithelial and vascular cells.
HEPES: pH stability outside CO2
25 mM HEPES helps prevent pH rise during open-air suspension handling, flow cytometry prep, and multi-well assay setup outside a CO2 incubator.
Low endotoxin release specification
< 0.05 EU/mL endotoxin release specification — below the threshold conventionally associated with TLR4 activation, relevant to preventing confounding fibroblast activation, neuroinflammatory signaling, and epithelial barrier disruption in primary cell assays.
NEAA reduces metabolic burden
Pre-loaded NEAA reduces de novo synthesis burden on primary cells, supporting viability in low-serum conditions and reducing ammonia accumulation.
Customization on demand
pH, glucose, HEPES concentration and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration passes reaching a final 0.04 µm polish under ISO Class 5 aseptic fill conditions. The train is a repeated prefilter-plus-final-filter pair run twice, not a single descending cascade.
-
1
0.1 µm Prefiltration I
Removes large aggregates and cell debris; protects the first 0.04 µm cartridge.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates, including the 0.2–0.3 µm size range associated with mycoplasma.
-
3
0.1 µm Prefiltration II
Second dedicated prefilter, protecting the second 0.04 µm cartridge.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter under ISO Class 5 aseptic fill & finish.
Performance vs. conventional media
© Diagnocine® — DCP-MEMGH-PR1X
Primary cell models and OoC applications
FluxMPS™ DCP-MEMGH-PR1X is formulated for primary neurons and related primary cell models, with 0.04 µm filtration purity for microfluidic platform compatibility.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant of this formulation is available on request for automated bioreactors and robotic liquid handling systems.
- Total Particulate Exclusion: 0.01 µm filtration removes nanoparticulate aggregates beyond the 0.04 µm cut-off.
- Valve & Sensor Protection: Reduces micro-fouling risk in delicate chip geometries.
- Extended Perfusion Stability: Supports consistent nutrient delivery over long-duration culture.
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Neuronal Chips & Brain-on-Chip
MEM + Earle's Salts + NEAA provides a physiologically balanced base for primary cortical neurons, DRG neurons, and iPSC-derived neuronal networks in compartmentalized chips.
Epithelium-on-Chip
MEM with NEAA supports primary epithelial cells and barrier integrity in transwell and microfluidic TEER-monitored platforms.
Primary Fibroblast & Stromal Models
MEM with NEAA is a classical base for primary dermal, lung and cardiac fibroblasts in low-serum or serum-free OoC conditions.
Vascular Cell Culture
Earle's salt ionic balance supports vascular smooth muscle cells and primary endothelial co-culture models on vascular-on-chip platforms.
Organ-on-a-Chip & MPS
0.04 µm filtered MEM helps prevent particulate clogging in sub-100 µm neuronal and epithelial chip microchannels.
Microscopy & Optical Sensing
Ultra-low particulate levels and a phenol red–free formulation reduce optical interference for confocal imaging, TEER sensors and biosensor applications on primary cell chips. Note: this formulation retains riboflavin, which itself contributes background fluorescence at its own excitation/emission range.
Analytical release specifications
Every batch released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] L-Glutamine, [+] Sodium Bicarbonate, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Glucose | [-] Phenol Red, [-] Sodium Pyruvate |
| Media family | MEM High Glucose + NEAA + 25mM HEPES (Earle's Salts base) |
| Appearance | Pale yellow, clear solution (phenol red–free) |
| Glucose | 4500 mg/L (4.5 g/L, High Glucose) |
| HEPES | 25 mM (5958 mg/L), pKa 7.3 at 37°C |
| NEAA | Present (Gly, Ala, Asn, Asp, Glu, Pro, Ser) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 290–330 mOsm/kg H2O |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (batch release specification) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Ultrapure Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, protect from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | 5% CO2 recommended; sodium bicarbonate (2200 mg/L) provides primary buffering, with 25 mM HEPES supplementing pH stability outside the incubator |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
MEM High Glucose + NEAA + 25mM HEPES: 36 ingredients across 4 categories, verified per batch with CAS numbers. NEAA components are listed under AMINO ACIDS. HEPES (25 mM = 5958 mg/L, CAS 7365-45-9) is listed under OTHERS.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium bicarbonate | 144-55-8 | 2200.000 |
| Sodium chloride | 7647-14-5 | 6800.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 122.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 7.500 |
| L-Alanine | 56-41-7 | 8.900 |
| L-Arginine hydrochloride | 1119-34-2 | 126.000 |
| L-Asparagine monohydrate | 5794-13-8 | 15.000 |
| L-Aspartic acid | 56-84-8 | 13.300 |
| L-Cystine dihydrochloride | 30925-07-6 | 31.300 |
| L-Glutamic acid | 56-86-0 | 14.700 |
| L-Glutamine | 56-85-9 | 292.000 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 52.000 |
| L-Leucine | 61-90-5 | 52.000 |
| L-Lysine hydrochloride | 657-27-2 | 72.500 |
| L-Methionine | 63-68-3 | 15.000 |
| L-Phenylalanine | 63-91-2 | 32.000 |
| L-Proline | 147-85-3 | 11.500 |
| L-Serine | 56-45-1 | 10.500 |
| L-Threonine | 72-19-5 | 48.000 |
| L-Tryptophan | 73-22-3 | 10.000 |
| L-Tyrosine disodium salt dihydrate | 69847-15-0 | 51.900 |
| L-Valine | 72-18-4 | 46.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 1.000 |
| D-Ca-Pantothenate | 137-08-6 | 1.000 |
| Folic acid | 59-30-3 | 1.000 |
| Nicotinamide | 98-92-0 | 1.000 |
| Pyridoxal hydrochloride | 65-22-5 | 1.000 |
| Riboflavin | 83-88-5 | 0.100 |
| Thiamine hydrochloride | 67-03-8 | 1.000 |
| i-Inositol | 87-89-8 | 2.000 |
| OTHERS | ||
| D-Glucose | 50-99-7 | 4500.000 |
| HEPES | 7365-45-9 | 5958.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under an ISO 13485:2016–certified quality management system. Final QA at the Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm Type 1 water supports low trace-metal and organic carbon (TOC) content in the feedwater.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested; a Certificate of Analysis is issued for every batch.
Endotoxin — USP <85> BET
LAL assay; batch release specification < 0.05 EU/mL; assay sensitivity 0.005 EU/mL.
Particulate — USP <788> Method 1
Light obscuration; NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Target: 290–330 mOsm/kg H2O.
Documentation & CoA
Full CoA with raw-material traceability available for every batch on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-MEMGH-PR1X compares
FluxMPS™ DCP-MEMGH-PR1X vs. conventional 0.22 µm–filtered MEM formulations and published supplier specifications.
| Parameter | DCP-MEMGH-PR1X (FluxMPS™) | Conventional 0.22 µm–filtered media / published specifications |
|---|---|---|
| Grade | Microfluidics Suitable | Not specified |
| MEM + Earle's Salts + NEAA + 25 mM HEPES, without sodium pyruvate and without phenol red | check_circle Yes | cancel Uncommon combination |
| Final filtration pore size | 0.04 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple) | 1 |
| Mycoplasma-retentive filtration | check_circle Yes (0.1 µm stage) | cancel No |
| Endotoxin (release specification) | FluxMPS™ — < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
| USP <788> particulate tested (Method 1) | check_circle Yes | cancel Not specified |
| Water quality | Ultrapure Type 1, 18.2 MΩ·cm | Purified water (grade often unspecified) |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or unspecified |
| Microfluidic channel compatibility | check_circle Microfluidics Suitable (0.04 µm filtered) | cancel Risk of channel clogging |
| Custom formulation available | check_circle Yes | cancel Typically no |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-MEMGH-PR1X.
Supporting literature
Key publications supporting MEM High Glucose + NEAA + 25mM HEPES in primary cell and OoC applications.
- Eagle H. Amino acid metabolism in mammalian cell cultures. Science. 1959;130:432–437. doi:10.1126/science.130.3373.432
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Campisi M, et al. 3D self-organized microvascular model of the human blood-brain barrier. Biomaterials. 2018;180:117–129. doi:10.1016/j.biomaterials.2018.07.014
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j

